LabForce: First system in Switzerland with NASA-level super large imaging chip Verified listing

Thursday, June 15, 2023 @ 12:00 am

The first successful attempt in emploring extra large photosensitive chip into Western Blot Imaging System, creating a next generation of chemiluminescent imaging

LabForce launched the first non-camera based chemiluminescent imaging system (e-BLOT) for the Swiss market. Main feature is a hughe photosensitive chip that needs no cooling and enables >100 times the sensitivity and dynamic range of high end camera systems.

You may also be interested in

Beware of fraudulent emails impersonating the Swiss Biotech Association

Don’t fall for fraudsters! Cyber criminals can reach you easily with today's communication means. We regularly detect fraudulent emails attempting to steal your passwords — both personal and for our systems — through phishing attacks. Smishing (SMS, text messages) or vishing (phone calls) are also a common way to retrieve information from you. With seemingly legitimate messages the criminals
October 8, 2024

InSphero and PharmaNest: Partnership to advance translational fibrosis research

InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company.
February 11, 2026

Industry leaders form alliance for microphysiological systems

A new united voice for a strategic sector for Europe
February 10, 2026

Akceso Advisors elects Seng Chin Mah as board member

Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non-executive member of its Board of Directors.
February 10, 2026

abc biopply: New organoid competence center in Basel

abc biopply announces today the opening of its new Organoid Competence Center at the Swiss Innovation Park Basel. With this new location, the company expands its portfolio of highly standardized and fully integrated Organoid CRO services and brings them for the first time to Basel — one of the world’s leading hubs for drug discovery and development.
February 5, 2026

Cosmo: Substantial private placement with Capital Group

February 3, 2026

LabForce: First system in Switzerland with NASA-level super large imaging chip Verified listing

LabForce: First system in Switzerland with NASA-level super large imaging chip Verified listing

Company

You may also be interested in

Beware of fraudulent emails impersonating the Swiss Biotech Association

InSphero and PharmaNest: Partnership to advance translational fibrosis research

Industry leaders form alliance for microphysiological systems

Akceso Advisors elects Seng Chin Mah as board member

abc biopply: New organoid competence center in Basel

Cosmo: Substantial private placement with Capital Group